Henry Schein, Inc. (HSIC) Coverage Initiated by Analysts at Morgan Stanley
A number of other equities analysts have also recently commented on the stock. Credit Suisse Group reissued a hold rating and issued a $87.50 price objective on shares of Henry Schein in a research note on Tuesday, August 29th. Zacks Investment Research cut shares of Henry Schein from a buy rating to a hold rating in a research note on Friday, June 23rd. Stifel Nicolaus reissued a hold rating on shares of Henry Schein in a research note on Thursday, July 6th. Piper Jaffray Companies raised shares of Henry Schein from a neutral rating to an overweight rating in a research note on Friday, September 15th. Finally, Jefferies Group LLC reissued a hold rating and issued a $88.50 price objective on shares of Henry Schein in a research note on Friday, July 21st. One analyst has rated the stock with a sell rating, eleven have given a hold rating and seven have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $92.85.
Henry Schein (HSIC) traded up 0.24% on Thursday, hitting $79.51. 1,160,611 shares of the stock were exchanged. The company has a 50-day moving average of $85.78 and a 200 day moving average of $88.02. Henry Schein has a 12 month low of $73.11 and a 12 month high of $93.50. The firm has a market cap of $6.29 billion, a P/E ratio of 11.62 and a beta of 1.10.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period last year, the company posted $0.82 EPS. The business’s revenue was up 6.4% on a year-over-year basis. Equities research analysts expect that Henry Schein will post $3.64 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Henry Schein, Inc. (HSIC) Coverage Initiated by Analysts at Morgan Stanley” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/henry-schein-inc-hsic-coverage-initiated-by-analysts-at-morgan-stanley/1581025.html.
Henry Schein announced that its Board of Directors has authorized a share repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in shares. This buyback authorization authorizes the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board of directors believes its stock is undervalued.
In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.27% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Eads & Heald Investment Counsel lifted its holdings in Henry Schein by 0.5% during the 2nd quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after buying an additional 8 shares in the last quarter. Cleararc Capital Inc. lifted its holdings in Henry Schein by 0.6% during the 1st quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after buying an additional 11 shares in the last quarter. Intrust Bank NA lifted its holdings in Henry Schein by 1.1% during the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares in the last quarter. Penserra Capital Management LLC lifted its holdings in Henry Schein by 1.0% during the 1st quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock valued at $258,000 after buying an additional 15 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Henry Schein by 0.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares in the last quarter. Institutional investors own 89.05% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.